|
| Status |
Public on Apr 13, 2020 |
| Title |
A TFAP2C Gene Signature is Predictive of Outcome in HER2 Breast Cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
31619506 |
| |
| Submission date |
Feb 21, 2019 |
| Last update date |
Apr 15, 2020 |
| Contact name |
Tiandao Li |
| Organization name |
Washington University
|
| Street address |
4444 Forest Park Ave
|
| City |
St Louis |
| State/province |
MO |
| ZIP/Postal code |
63108 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL9052 |
Illumina Genome Analyzer (Homo sapiens) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (26)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE126894 |
A TFAP2C Gene Signature is Predictive of Outcome in HER2 Breast Cancer (RNA-Seq) |
| GSE126897 |
A TFAP2C Gene Signature is Predictive of Outcome in HER2 Breast Cancer (ChIP-Seq) |
|
| Relations |
| BioProject |
PRJNA523611 |
Less...
More...